tradingkey.logo
tradingkey.logo
Search

Adaptive Biotechnologies Corp

ADPT
Add to Watchlist
27.670USD
+0.990+3.71%
Close 09-16 16:00ET
4.41BMarket Cap
LossP/E TTM
After-hours 18:42 (ET)27.880USD+0.235+0.85%
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

+3.71%

5 Days

+13.31%

1 Month

+11.84%

6 Months

+107.73%

Year to Date

+70.38%

1 Year

+114.33%

Key Figures

27.090Open
28.720High
695.79KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.44%Turnover Ratio
26.680Prev. Close
27.030Low
19.24MTurnover
LossP/E Static
30.83P/B
0.00%Div Yield TTM
-9.76%ROA
28.72052wk High
146.34Volume Ratio
-159.49MNet Profit
159.06MShares
-0.3209EPS TTM
2.16Beta
-24.43%ROE
12.00052wk Low
6.11%Amplitude
72.12%Gross Margin
4.41BMarket Cap
3.36Reward/Risk
4.34%Risk Rate
More news coming soon, stay tuned...

Adaptive Biotechnologies Corp's Score

0.07vs previous score
Forecast8.50
Financial Health8.01
Technical4.31
Valuation Dimensions9.72
Institutional Confidence10.00
Risk Assessment5.54

Media Coverage

Coverage Level

Very Low
Very High
Positive

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
BuyCurrent Rating
24.750Target Price
-7.23%Upside Space
Current Rating2026-092026-082026-072026-062026-052026-042026-032026-02
Strong Buy33333333
Buy44444444
Hold11111111
Sell00000000
Strong Sell00000000

Adaptive Biotechnologies Corp Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D

Technical Indicators

Strong buy

Summary

Buy

Moving Average

Strong buy

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.25/-0.13
Revenue / Forecast
71.55M/65.89M

Adaptive Biotechnologies Corp Profile

SectorBiotechnology & Medical Research
Ticker SymbolADPT
Number of employees619
CountryUnited States of America

Ownership

ShareholdersProportion
Viking Global Investors LP18.74%
BlackRock Institutional Trust Company, N.A.6.92%
Vanguard Capital Management, LLC3.81%
Westfield Capital Management Company, L.P.3.40%
Shareholder TypesProportion
Investment Advisor/Hedge Fund46.81%
Investment Advisor40.11%
Hedge Fund5.05%
Individual Investor2.10%

FAQs

What is the current price of Adaptive Biotechnologies Corp (ADPT)?

The current price of Adaptive Biotechnologies Corp (ADPT) is 27.67.

What is the symbol of Adaptive Biotechnologies Corp?

The ticker symbol of Adaptive Biotechnologies Corp is ADPT.

What is the 52-week high of Adaptive Biotechnologies Corp?

The 52-week high of Adaptive Biotechnologies Corp is 28.67.

What is the 52-week low of Adaptive Biotechnologies Corp?

The 52-week low of Adaptive Biotechnologies Corp is 12.00.

What is the market capitalization of Adaptive Biotechnologies Corp?

The market capitalization of Adaptive Biotechnologies Corp is 4.41B.

Is Adaptive Biotechnologies Corp (ADPT) currently rated as Buy, Hold, or Sell?

According to analysts, Adaptive Biotechnologies Corp (ADPT) has an overall rating of Buy, with a price target of 24.75.

What is the Earnings Per Share (EPS TTM) of Adaptive Biotechnologies Corp (ADPT)?

The Earnings Per Share (EPS TTM) of Adaptive Biotechnologies Corp (ADPT) is -0.32.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.